← Back to Search

Psychosocial Support Interventions for Pediatric Cancer (PAT Trial)

N/A
Waitlist Available
Research Sponsored by Nemours Children's Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 and 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will study two ways to help pediatric cancer programs provide better psychological support to patients and families.

Who is the study for?
This trial is for pediatric cancer programs in the U.S. that have a psychosocial staff size at or above the median level. Eligible sites must serve a significant number of new pediatric cancer patients, including Spanish speakers and families with low socioeconomic status.
What is being tested?
The study compares two strategies to implement the Psychosocial Assessment Tool (PAT) across 18 pediatric cancer centers. One group will receive Training Webinar Plus Implementation Enhanced Resources (TIER), while another just gets a training webinar.
What are the potential side effects?
Since this trial focuses on implementing an assessment tool rather than medical treatment, it does not involve direct physical side effects. However, there may be indirect impacts on patient care based on how well each strategy works.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of Intervention Measure (AIM)
Ethnic minority families screened
Families provided feedback
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Strategy I.TrainingActive Control1 Intervention
Sites randomized to Strategy I will receive a three hour training webinar in preparing for implementation of the PAT in their center.
Group II: Strategy II.Training+Implementation Enhanced Resources (TIER)Active Control2 Interventions
Sites randomized to Strategy II will identify a Champion for screening and will participate in a monthly consultation call in addition to completing the three hour training webinar for implementing the PAT in their center.

Find a Location

Who is running the clinical trial?

Nemours Children's ClinicLead Sponsor
127 Previous Clinical Trials
18,405 Total Patients Enrolled
Children's Hospital of PhiladelphiaOTHER
731 Previous Clinical Trials
8,473,016 Total Patients Enrolled
American Cancer Society, Inc.OTHER
231 Previous Clinical Trials
109,693 Total Patients Enrolled

Media Library

Strategy I.Training Clinical Trial Eligibility Overview. Trial Name: NCT04446728 — N/A
Pediatric Cancer Research Study Groups: Strategy I.Training, Strategy II.Training+Implementation Enhanced Resources (TIER)
Pediatric Cancer Clinical Trial 2023: Strategy I.Training Highlights & Side Effects. Trial Name: NCT04446728 — N/A
Strategy I.Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT04446728 — N/A
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top